Literature DB >> 33963752

Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020.

Lao-Tzu Allan-Blitz1, Jeffrey D Klausner2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33963752      PMCID： PMC8135970          DOI： 10.1093/infdis/jiab245

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  3 in total

1.  Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile.

Authors:  Pablo Vial; Claudia González; Gloria Icaza; Muriel Ramirez-Santana; Rubén Quezada-Gaete; Loreto Núñez-Franz; Mauricio Apablaza; Cecilia Vial; Paola Rubilar; Juan Correa; Claudia Pérez; Andrei Florea; Eugenio Guzmán; María-Estela Lavín; Paula Concha; Manuel Nájera; Ximena Aguilera
Journal:  BMC Infect Dis       Date:  2022-01-28       Impact factor: 3.090

2.  Socioeconomic Disparities in Severe Acute Respiratory Syndrome Coronavirus 2 Serological Testing and Positivity in New York City.

Authors:  Wil Lieberman-Cribbin; Marta Galanti; Jeffrey Shaman
Journal:  Open Forum Infect Dis       Date:  2021-10-17       Impact factor: 3.835

3.  Predictors of Nonseroconversion after SARS-CoV-2 Infection.

Authors:  Weimin Liu; Ronnie M Russell; Frederic Bibollet-Ruche; Ashwin N Skelly; Scott Sherrill-Mix; Drew A Freeman; Regina Stoltz; Emily Lindemuth; Fang-Hua Lee; Sarah Sterrett; Katharine J Bar; Nathaniel Erdmann; Sigrid Gouma; Scott E Hensley; Thomas Ketas; Albert Cupo; Victor M Cruz Portillo; John P Moore; Paul D Bieniasz; Theodora Hatziioannou; Greer Massey; Mary-Beth Minyard; Michael S Saag; Randall S Davis; George M Shaw; William J Britt; Sixto M Leal; Paul Goepfert; Beatrice H Hahn
Journal:  Emerg Infect Dis       Date:  2021-06-30       Impact factor: 6.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.